Riskpilot← Back to searchSign inGet full accessCuspiden AB
ABBankruptOrg 5565381224LidingöDental practice care activities · NACE 8623Est. 19970 employees
Revenue 2024
SEK 2,4M
+41% vs 2023
EBITDA margin
-43.8%
-14% vs 2023
Equity ratio
28.6%
Financial strength
Net profit 2024
SEK -4K
+98% vs 2023
| Revenue | SEK 2,4M | +41% |
| EBITDA | SEK -1M | -14% |
| Net profit | SEK -4K | +98% |
| Total assets | SEK 855K | -44% |
| Equity | SEK 245K | -1% |
| Employees | 0 | — |
Legal name
Cuspiden AB
Org number
5565381224
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
21 januari 1997
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är tandläkarpraktik, handel med värdepapper och därmed förenlig verksamhet.
Address
Lidingö
Phone
+46705457970
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 918 | 2 752 | 3 204 | 1 677 | 2 363 |
| Staff expenses | — | — | — | −1 272 | −1 611 |
| EBITDA | −259 | −178 | 142 | −904 | −1 035 |
| Depreciation & amort. | −6 | −6 | −6 | −6 | −6 |
| EBIT | −265 | −184 | 136 | −910 | −1 041 |
| Net financials | −4 | 21 | −1 | 741 | 1 037 |
| Profit before tax | −269 | −162 | 135 | −169 | −4 |
| Tax | −0 | −1 | −0 | — | — |
| Net profit | −269 | −163 | 135 | −169 | −4 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 140 | 935 | 1 370 | 1 525 | 855 |
| Equity | 446 | 283 | 418 | 248 | 245 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 694 | 652 | 952 | 1 277 | 610 |
| Total debt | 694 | 652 | 952 | 1 277 | 610 |
EBITDA margin
-43.8%
This company
15.8%
Market median
-377% vs market
20202024
Equity ratio
28.6%
This company
38.2%
Market median
-25% vs market
20202024
Return on equity
-1.5%
This company
18.4%
Market median
-108% vs market
20202024
Net profit margin
-0.2%
This company
8.1%
Market median
-102% vs market
20202024
Asset turnover
2.76×
This company
1.12×
Market median
+146% vs market
20202024
Debt / equity
2.49×
This company
0.62×
Market median
-302% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-09-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TANDSAM AB
Cuspiden AB Board members of Cuspiden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Ingemar Björn | Deputy Board Member | 0 companies |
| Marina Avesten | Deputy Board Member | 0 companies |
| Rolf Lennart Avesten | Board of Directors | 0 companies |